Intimation of Issuance of Duplicate Share Certificate
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Oxygenta Pharmaceutical Ltd has informed BSE about the issuance of a duplicate share certificate under SEBI LODR Regulation 39(3). The duplicate was issued to shareholder Venkatesh G Rao (Folio No. SSO112227) because the original certificate (No. 50779) covering 100 shares with distinctive numbers 5077801 to 5077900 was reported lost or misplaced. The new certificate issued bears No. 56284. The intimation was signed by Kumkum Bajaj, Company Secretary & Compliance Officer, on 18 October 2025.
This is a routine procedural disclosure with no material impact on the company's operations, financials, or shareholder value. Duplicate share certificate issuances are standard regulatory disclosures whenever an investor loses original share documents.